BioMed Research International / 2013 / Article / Tab 1

Clinical Study

Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool

Table 1

Patient and tumor characteristics.

CharacteristicValue

Age
Median (range)
62 (28–65)
Clinical Stage*
 IIB1
 IIIA1
 IIIB-IIIC3
Tumor diameter in mm
Median (range)
88 (75–160)
Laterality
 Right sided 3
 Left sided2
Hormonal receptors and HER2 over-expression
 ER−, PR−, HER2−2
 ER+, PR−, HER2−1
 ER+, PR+, HER2−1
 ER−, PR−, HER2+1
Histological grade
 21
 34
Number of mitoses/10 high power field
 <111
 >224
Initial chemotherapy regimen before HT
 EC + docetaxel3
 FEC + docetaxel1
 Docetaxel + trastuzumab1
Adjuvant hormonotherapy
 Yes2
 No3

Abbreviations: ER: oestrogen receptor, PR: progesterone receptor, HER2: Human Epidermal Growth Factor Receptor 2, *AJCC Cancer Staging Manual, Seventh Edition (2010), EC: epirubicin, cyclophosphamide, FEC: 5fluorouracil, epirubicin, cyclophosphamide, Elston-Ellis modification of Scarff-Bloom-Richardson grading system.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.